Search results for " Osteonecrosis of the jaw"

showing 10 items of 85 documents

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on La…

2018

The recent randomized trial, published by Raje et al., on Lancet Oncology is potentially practice changing. It proposes that denosumab is a valid alternative to zoledronic acid in the treatment of myeloma patients. However, several points need further data and more details, such as information on incidence, diagnosis, and follow-up of osteonecrosis of the jaw (ONJ) cases, observed among treated patients. Adopted definition to adjudicate ONJ cases, type of registration of potential ONJ cases, length of observation are possible causes of potential underestimation of ONJ incidence in their study. Future updated evaluations with longer follow-up, and including actuarial estimation, are required…

Oncologyosteonecrosimedicine.medical_specialtyONJMRONJ; ONJ; denosumab; jaw; medication-related osteonecrosis of the jaw; multiple myeloma; osteonecrosis; osteonecrosis of the jaw; zoledronic acidMRONJlaw.invention03 medical and health scienceszoledronic acid0302 clinical medicinejawRandomized controlled triallawInternal medicinemedicinemedication-related osteonecrosis of the jawGeneral DentistryMultiple myelomabusiness.industryIncidence (epidemiology)Commentosteonecrosisdenosumab030206 dentistrymedicine.diseaselcsh:RK1-715multiple myelomaosteonecrosis of the jawDenosumabZoledronic acid030220 oncology & carcinogenesislcsh:DentistrybusinessOsteonecrosis of the jawmedicine.drugDentistry journal
researchProduct

Oral squamous cell carcinoma mimicking osteonecrosis of the jaw: a case report

2021

Oral squamous cell carcinoma osteonecrosis of the jaw case report
researchProduct

Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series

2010

Abstract Purpose To report a case series of patients with the nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw—a form of jaw osteonecrosis that does not manifest with necrotic bone exposure/mucosal fenestration. Methods Among 332 individuals referred to 5 clinical centers in Europe because of development of jawbone abnormalities after or during exposure to bisphosphonates, we identified a total of 96 patients who presented with the nonexposed variant of osteonecrosis. Relevant data were obtained via clinical notes; radiological investigations; patients' history, and referral letters. Results The most common clinical feature of nonexposed osteonecrosis was jaw bone pa…

OsteochemonecrosisMaleTime FactorsAvascular necrosisMandibleAvascular necrosiEpidemiologyMaxillaProspective cohort studyMultiple myelomaAged 80 and overeducation.field_of_studyAlendronateBone Density Conservation AgentsDiphosphonatesOsteochemonecrosiOsteonecrosisGeneral MedicineBisphosphonatesMiddle AgedKidney NeoplasmsEuropeAvascular necrosisFemaleMultiple MyelomaAdultmedicine.medical_specialtyPopulationJawsBreast NeoplasmsSettore MED/28 - Malattie OdontostomatologicheJawbonesmedicineHumansBisphosphonateeducationAgedBisphosphonate-associated osteonecrosis of the jawbusiness.industryProstatic NeoplasmsAvascular necrosis; Bisphosphonates; Jawbones; Jaws; Mandible; Maxilla; Osteochemonecrosis; Osteonecrosismedicine.diseaseDermatologySurgeryJawMaxillaOsteoporosisJawbonebusinessOsteonecrosis of the jawJaw Diseases
researchProduct

Ozone gas insufflation and infiltration for conservative surgical treatment of osteonecrosis of the jaw: preliminary results at 3 months

2018

the aim of this study was to evaluate efficacy and safety of ozone insufflation/injection in conservative surgical approaches of oNJ in two cancer patients.

Ozone gas conservative surgical treatment osteonecrosis of the jaw
researchProduct

PREVENTION OF THE DRUG-RELATED OSTEONECROSIS OF THE JAW (ONJ): PRELIMINARY DATA OF THE PROMaF PROTOCOL

2018

PREVENTION DRUG-RELATED OSTEONECROSIS OF THE JAW PROMaF PROTOCOL
researchProduct

Effects of a low-level diode laser on oral keratinocytes, oral fibroblasts, endothelial cells and osteoblasts incubated with bisphosphonates: An

2014

Bisphosphonate-associated osteonecrosis of the jaw may have multiple causes, including altered bone remodeling, angiogenesis inhibition and impact of bisphosphonate on the soft tissues. Successful treatment is difficult. As a positive effect of low-level laser application on wound healing is well known, an in vitro study was designed to analyze the effect of low-level laser (280 mW, 670 nm) treatment on keratinocytes, fibroblasts, endothelial cells and osteoblasts treated with clodronate, ibandronate, pamidronate or zoledronate. Pure irradiation had a positive effect on cell viability, whereas bisphosphonate treatment had a negative impact. Viability was significantly increased in cells tre…

Pathologymedicine.medical_specialtyBisphosphonate-associated osteonecrosis of the jawbusiness.industryGeneral Neurosciencemedicine.medical_treatmentCellGeneral MedicineArticlesBisphosphonatemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyBone remodelingmedicine.anatomical_structureApoptosismedicineCancer researchViability assayGeneral Pharmacology Toxicology and PharmaceuticsWound healingOsteonecrosis of the jawbusinessBiomedical reports
researchProduct

Bisphosphonate-related osteonecrosis. Application of adipose-derived stem cells in an experimental murine model

2019

Background Bisphosphonate-related osteonecrosis of the jaw is a pathological condition without effective established treatment and preventive strategies. The aim of this study was to analyse the effect of adipose-derived stem cells (ASC) in an experimental murine model of osteonecrosis. Material and Methods 38 Wistar rats were injected intraperitoneally with zoledronic acid. After treatment, upper jaw molars were extracted. The animals were randomly assigned to one of two groups. In the control group, saline solution was applied over the alveolar sockets after the tooth extractions. In the treatment group, ASCs were applied instead of saline solution. The control and treatment groups were s…

Pathologymedicine.medical_specialtymedicine.medical_treatmentReviewBone remodelingMice03 medical and health sciences0302 clinical medicinemedicineAnimalsRats WistarGeneral DentistryDental alveolusBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industryStem CellsImidazolesOsteonecrosis030206 dentistryBisphosphonate:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseRatsDisease Models AnimalBone Density Conservation AgentsZoledronic acidOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASTooth ExtractionBisphosphonate-Associated Osteonecrosis of the JawSurgeryOral SurgeryStem cellbusinessOsteonecrosis of the jawmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning m…

2021

Objective: In the recent years, an increasing number of peri-implant medication-related osteonecrosis of the jaw (PI-MRONJ) have been reported in literature, both in oncologic and osteoporotic patients. The aim of this study is to describe 19 cases of patients previously diagnosed as affected by peri-implantitis, who were treated for PI-MRONJ, with consideration on clinical and histopathological features. Materials and Methods: Patients included were affected by postmenopausal osteoporosis and were administered with different antiresorptive drugs. Due to the presence of clinical and radiological signs of peri-implantitis not healed after non-surgical periodontal treatment, they were referre…

Peri-implantitisConfocal laser scanning microscopeDentistryantiangiogenic drugs; antiresorptive drugs; bisphosphonates; medication-related osteonecrosis of the jaw; peri-implantitis03 medical and health sciences0302 clinical medicineMedicineHumansantiresorptive drugsmedication-related osteonecrosis of the jawantiangiogenic drugsDental CareGeneral DentistryPathologicalbisphosphonatesWound HealingBone Density Conservation AgentsDiphosphonatesLS7_8business.industryAmbientale030206 dentistryDrug holidaymedicine.diseaseAntiresorptive DrugsOtorhinolaryngology030220 oncology & carcinogenesisRadiological weaponBisphosphonate-Associated Osteonecrosis of the JawImplantbusinessOsteonecrosis of the jawperi-implantitis
researchProduct

Proceedings of the Closed Round Table and Italian Consensus on the Medication-Related Osteonecrosis of Jaws (MRONJ) at the Symposium of Italian Socie…

2019

On 20 October 2018 a Closed Round Table brought together a wide range of stakeholders from several medical disciplines, including academic experts, dentists, oncologists, maxillo-facial surgeons, oral surgeons, radiologists, under the technical and scientific coordination of Giuseppina Campisi (for SIPMO) and Giacomo Oteri (for Italian Society of Oral Surgery- SIdCO)

SIPMOBRONJ (bisphosphonate-related osteonecrosis of the jaw)Risk of inappropriatenessSIdCOPhysiologyPhysiology (medical)Italian consensus mrojMRONJ Italian ConsensusMRONJONJ (osteonecrosis of the jaws)BRONJ (bisphosphonate-related osteonecrosis of the jaw)Risk of inappropriatenessMRONJ Italian ConsensusSIPMOSIdCOMRONJONJ (osteonecrosis of the jaws)
researchProduct

Surgical treatment of medication-related osteonecrosis of the jaws with addiction of L-PRF: preliminary results

2018

Surgical treatment medication-related osteonecrosis of the jaws L-PRF
researchProduct